Making best use of bone turnover markers to monitor oral bisphosphonate therapy

[摘要] We now have more agents than ever before to treat osteoporosis, including newer anabolic drugs such as teriparatide, abaloparatide, and romosozumab that increase bone formation and are extremely effective at preventing fractures. But the oral bisphosphonates remain the most widely prescribed antifracture drugs and continue to pose clinical challenges such as measuring therapeutic efficacy and ensuring patient adherence.

[学科分类] 卫生学